High Carbapenem Resistance in Clinical Gram-Negative Pathogens Isolated in Egypt

Microbial Drug Resistance

Volumn 23, Issue 7, 2017, Pages 838-844

  Khalifa, Hazim O ^a,b   Soliman, Ahmed M ^a,c   Ahmed, Ashraf M ^a,b   Shimamoto, Toshi ^a   Hara, Toshinori ^a   Ikeda, Mitsuyasu ^a   Kuroo, Yuta ^a,d   Kayama, Shizuo ^a   Sugai, Motoyuki ^a   Shimamoto, Tadashi ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b Kafrelsheikh University   (Egypt)

^c Kafrelsheikh University   (Egypt)

^d HIROSHIMA UNIVERSITY   (Japan)

Author keywords

carbapenemases; Egypt; Escherichia coli; Klebsiella pneumoniae; Pseudomonas aeruginosa; Serratia marcescens

Indexed keywords

ADENOSINE PHOSPHATE; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZTREONAM; CARBAPENEM; CEFTAZIDIME; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; DORIPENEM; GENTAMICIN; IMIPENEM; MEROPENEM; METALLO BETA LACTAMASE; NALIDIXIC ACID; TETRACYCLINE; ZIDOVUDINE; ANTIINFECTIVE AGENT; BETA LACTAMASE; CARBAPENEM DERIVATIVE;

AMINO ACID SEQUENCE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; EGYPT; ESCHERICHIA COLI; GENOTYPE; GRAM NEGATIVE BACTERIUM; HOSPITAL PATIENT; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; MORGANELLA MORGANII; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROVIDENCIA RETTGERI; PROVIDENCIA STUARTII; PSEUDOMONAS AERUGINOSA; SALMONELLA ARIZONAE; SERRATIA MARCESCENS; BETA-LACTAM RESISTANCE; CLASSIFICATION; DRUG EFFECT; ENTEROBACTERIACEAE INFECTION; ESCHERICHIA COLI INFECTION; GENE EXPRESSION; GENETICS; HOSPITAL; HUMAN; INTEGRON; ISOLATION AND PURIFICATION; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PHYLOGENY; PSEUDOMONAS INFECTION; SERRATIA INFECTION;

ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CARBAPENEMS; EGYPT; ENTEROBACTERIACEAE INFECTIONS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GENE EXPRESSION; HOSPITALS; HUMANS; INTEGRONS; MICROBIAL SENSITIVITY TESTS; MORGANELLA MORGANII; PHYLOGENY; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SERRATIA INFECTIONS; SERRATIA MARCESCENS;

EID: 85031281689     PISSN: 10766294     EISSN: 19318448     Source Type: Journal    
DOI: 10.1089/mdr.2015.0339     Document Type: Article

References (24)

1. Centers for Disease Control, Prevention (CDC). 2013. Antibiotic resistance threats to the United States, 2013. Available at www. cdc. gov/drugresistance/threat-report-2013/ pdf/ar-threats-2013-508. pdf (accessed on 5th February 2017).
2. Memish, Z. A., A. Assiri, M. Almasri, H. Roshdy, H. Hathout, M. Kaase, S. G. Gatermann, and S. Yezli. 2015. Molecular characterization of carbapenemase production among Gram-negative bacteria in Saudi Arabia. Microb. Drug Resist. 21:307-314.
3. Sekyere, J. O., U. Govinden, and S. Essack. 2015. The molecular epidemiology and genetic environment of carbapenemases detected in Africa. Microb. Drug Resist. 22: 59-68.
4. Queenan, A. M., and K. Bush. 2007. Carbapenemases: The versatile b-lactamases. Clin. Microbiol. Rev. 20:440-458.
5. Dortet, L., L. Poirel, and P. Nordmann. 2014. Worldwide dissemination of the NDM-type carbapenemases in Gramnegative bacteria. BioMed. Res. Int. 2014:249856.
6. Abdelaziz, M. O., C. Bonura, A. Aleo, T. Fasciana, and C. Mammina. 2013. NDM-1-and OXA-163-producing Klebsiella pneumoniae isolates in Cairo, Egypt, 2012. J. Glob. Antimicrob. Resist. 1:213-215.
7. Diab M., N. Fam, M. El-Said, E. El-Dabaa, I. El-Defrawy, and M. Saber. 2013. Occurrence of VIM-2 metallo-blactamases in imipenem resistant and susceptible Pseudomonas aeruginosa clinical isolates from Egypt. Afr. J. Microbiol. Res. 7:4465-4472.
8. Helal, S. F., N. G. El-Rachidi, E. M. Abdul Rahman, and D. M. Hassan. 2014. The presence of blaKPC-mediated resistance in Enterobacteriaceae in Cairo University hospitals in Egypt and its correlation with in vitro carbapenem susceptibility. J. Chemother. 26:125-128.
9. Poirel, L., M. O. Abdelaziz, S. Bernabeu, and P. Nordmann. 2013. Occurrence of OXA-48 and VIM-1 carbapenemaseproducing Enterobacteriaceae in Egypt. Int. J. Antimicrob. Agents 41:90-91.
10. Zafer M. M., M. H. Al-Agamy, H. A. El-Mahallawy, M. A. Amin, and S. El Din Ashour. 2015. Dissemination of VIM-2 producing Pseudomonas aeruginosa ST233 at tertiary care hospitals in Egypt. BMC Infect. Dis. 15:122.
11. Zafer, M. M., M. H. Al-Agamy, H. A. El-Mahallawy, M. A. Amin, and M. S. Ashour. 2014. Antimicrobial resistance pattern and their beta-lactamase encoding genes among Pseudomonas aeruginosa strains isolated from cancer patients. Biomed. Res. Int. 2014:101635.
12. Turton, J. F., C. Perry, S. Elgohari, and C. V. Hampton. 2010. PCR characterization and typing of Klebsiella pneumoniae using capsular type-specific, variable number tandem repeat and virulence gene targets. J. Med. Microb. 59:541-547.
13. Clinical and Laboratory Standard Institute. 2012. Performance Standard for Antimicrobial Susceptibility Testing; Twenty Second Informational Supplement. M100-S22, Vol. 32, No. 3, Wayne, PA.
14. van der Zwaluw, K., A. de Haan, G. N. Pluister, H. J. Bootsma, A. J. de Neeling, and L. M. Schouls. 2015. The carbapenem inactivation method (CIM), a simple and lowcost alternative for the carba NP test to assess phenotypic carbapenemase activity in Gram-Negative rods. PLoS One. 10:e0123690.
15. Shibata, N., Y. Doi, K. Yamane, T. Yagi, H. Kurokawa, K. Shibayama, H. Kato, K. Kai, and Y. Arakawa. 2003. PCR typing of genetic determinants for metallo-b-lactamases and integrases carried by Gram-negative bacteria isolated in Japan, with focus on the class 3 integron. J. Clin. Microb. 41:5407-5413.
16. Ahmed A. M., T. Shimamoto, and T. Shimamoto. 2013. Molecular characterization of multidrug-resistant avian pathogenic Escherichia coli isolated from septicemic broilers. Int. J. Med. Microbiol. 303:475-483.
17. Poirel L., T. R. Walsh, V. Cuvillier, and P. Nordmann. 2011. Multiplex PCR for detection of acquired carbapenemase genes. Diagn. Microbiol. Infect. Dis. 70:119-123.
18. Sonnevend, Á., A. A. Ghazawi, R. Hashmey, W. Jamal, V. O. Rotimi, A. M. Shibl, A. Al-Jardani, S. S. Al-Abri, W. U. Tariq, S. Weber, and T. Pál. 2015. Characterization of carbapenem-resistant Enterobacteriaceae with high rate of autochthonous transmission in the Arabian Peninsula. PLoS One. 10:e0131372.
19. Chen, L. F., D. J. Anderson, and D. L. Paterson. 2012. Overview of the epidemiology and the threat of Klebsiella pneumoniae carbapenemases (KPC) resistance. Infect. Drug Resist. 5:133-141.
20. Wang, J., J. Y. Zhou, T. T. Qu, P. Shen, Z. Q. Wei, Y. S. Yu, and L. J. Li. 2010. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Chinese hospitals. Int. J. Antimicrob. Agents 35:486-491.
21. Gutierrez, O., C. Juan, E. Cercenado, F. Navarro, E. Bouza, P. Coll, J. L. Perez, and A. Oliver. 2007. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals. Antimicrob. Agents Chemother. 51:4329-4335.
22. Gruber T. M., S. Göttig, L. Mark, S. Christ, V. A. Kempf, T. A. Wichelhaus, and A. Hamprecht. 2014. Pathogenicity of pan-drug-resistant Serratia marcescens harbouring blaNDM-1. J. Antimicrob. Chemother. 70:1026-1030.
23. Mataseje L. F., D. A. Boyd, J. Delport, L. Hoang, M. Imperial, B. Lefebvre, M. Kuhn, P. Van Caeseele, B. M. Willey, and M. R. Mulvey. 2014. Serratia marcescens harbouring SMEtype class A carbapenemases in Canada and the presence of blaSME on a novel genomic island, SmarGI1-1. J. Antimicrob. Chemother. 69:1825-1829.
24. Jamal, W. Y., M. J. Albert, F. Khodakhast, L. Poirel, and V. O. Rotimi. 2014. Emergence of new sequence type OXA-48 carbapenemase-producing Enterobacteriaceae in Kuwait. Microb. Drug Resist. 21:329-334.